Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
0.7000
-0.1584 (-18.45%)
At close: Mar 28, 2025, 4:00 PM
0.8288
+0.1288 (18.40%)
After-hours: Mar 28, 2025, 7:58 PM EDT
Accelerate Diagnostics Employees
Accelerate Diagnostics had 134 employees as of December 31, 2023. The number of employees decreased by 45 or -25.14% compared to the previous year.
Employees
134
Change (1Y)
-45
Growth (1Y)
-25.14%
Revenue / Employee
$87,299
Profits / Employee
-$373,470
Market Cap
17.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AXDX News
- 9 days ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 9 days ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 2 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 6 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 8 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha